New antiepileptic drugs.
Patsalos
P N
PN
University Department of Clinical Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
D000085:Acetates / Q000032:analysis / Q000493:pharmacokinetics / Q000627:therapeutic use; D000588:Amines; D000927:Anticonvulsants / Q000032:analysis / Q000493:pharmacokinetics / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids; D004347:Drug Interactions; D016903:Drug Monitoring; D005632:Fructose / Q000031:analogs & derivatives / Q000032:analysis / Q000493:pharmacokinetics / Q000627:therapeutic use; D000077206:Gabapentin; D006801:Humans; D000077213:Lamotrigine; D017410:Practice Guidelines as Topic; D000077236:Topiramate; D014227:Triazines / Q000032:analysis / Q000493:pharmacokinetics / Q000627:therapeutic use; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000032:analysis / Q000493:pharmacokinetics / Q000627:therapeutic use
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D014227:Triazines; D000077236:Topiramate; D005632:Fructose; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D020888:Vigabatrin; D000077213:Lamotrigine